P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

Detalles Bibliográficos
Autores principales: Kris Michael, Mahadeo, Robert, Baiocchi, Amer, Beitinjaneh, Sridhar, Chaganti, Choquet, Sylvain, Dierickx, Daan, Rajani, Dinavahi, Gamelin, Laurence, Ghobadi, Armin, Norma, Guzman-Becerra, Manher, Joshi, Aditi, Mehta, Sarah, Nikiforow, Ran, Reshef, Wei, Ye, Susan, Prockop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430751/
http://dx.doi.org/10.1097/01.HS9.0000972448.04902.65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430751/
http://dx.doi.org/10.1097/01.HS9.0000972448.04902.65

Ejemplares similares